A phase 1 study of the amino acid modulator pegcrisantaspase and venetoclax for relapsed/refractory acute myeloid leukemia.
Liu Y, Bollino DR, Bah OM, Strovel ET, Le TV, Zarrabi J, Philip S, Lapidus RG, Baer MR, Niyongere S, Duong VH, Dougherty CC, Beumer JH, Caprinolo KD, Kamangar F, Emadi A.
Liu Y, et al. Among authors: dougherty cc.
Blood. 2024 Oct 22:blood.2024024837. doi: 10.1182/blood.2024024837. Online ahead of print.
Blood. 2024.
PMID: 39437546